Futibatinib in Patients Previously Enrolled in an Antecedent Futibatinib as Monotherapy or Combination Therapy.

Severance Hospital, Seoul

Hospital Universitari, Vall d'Hebron, Barcelona

Institut Paoli-Calmettes, Marseille

Centro Integral Oncologico, Madrid

Institut De Cancerologie Strasbourg, Strasbourg

University of California, San Francisco (UCSF), San Francisco

Royal Marsden NHS Foundation Trust, London

Sarah Cannon Research Institute UK, London

University College London Hospitals NHS Foundation Trust, London